Harvard Bioscience, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $75.3M | $16.6M |
| FY2010 | $18.0M | $90.2M | $19.7M |
| FY2011 | $16.3M | $95.5M | $17.9M |
| FY2012 | $13.0M | $104.2M | $20.7M |
| FY2013 | $19.8M | $94.5M | $25.8M |
| FY2014 | $16.5M | $95.5M | $14.1M |
| FY2015 | $16.4M | $77.6M | $6.7M |
| FY2016 | $11.4M | $72.2M | $5.6M |
| FY2017 | $9.0M | $80.9M | $5.2M |
| FY2018 | $11.9M | $82.7M | $8.2M |
| FY2019 | $46.9M | $81.7M | $8.3M |
| FY2020 | $46.3M | $76.7M | $8.3M |
| FY2021 | $45.1M | $83.4M | $7.8M |
| FY2022 | $43.0M | $72.2M | $4.5M |
| FY2023 | $30.7M | $73.1M | $4.3M |
| FY2024 | $0 | $63.3M | $4.1M |
| FY2025 | $35.9M | $13.7M | $8.6M |